Humacyte 9 月份的空头股数上涨 14.4%，卖空 1603 万股。 14.4% rise in Humacyte's short interest in September, with 16.03 million shares sold short.

Humacyte， Inc.（纳斯达克股票代码：HUMA）9月份的空头股数增长了14.4%，总计1603万股，空头股数比率为5.1天。 Humacyte, Inc. (NASDAQ: HUMA) experienced a 14.4% rise in short interest in September, totaling 16.03 million shares, with a short-interest ratio of 5.1 days. 目前,其16.4%的股份被短价出售。 Currently, 16.4% of its shares are sold short. 中间商大多给予正面评级,基准价格目标为15美元。 Brokerages have mostly assigned positive ratings, with a $15 price target from Benchmark. 首席执行官劳拉·E·尼克拉松出售157 704股,每股5.42美元。 CEO Laura E. Niklason sold 157,704 shares at $5.42 each. 机构投资者占Humacyte的44.71%,其市场上限为6.9188亿美元。 Institutional investors hold 44.71% of Humacyte, which has a market cap of $691.88 million.

文章

Modern Readers

The Enterprise Leader

Biztoc

-- 显示更少 --

延伸阅读

相关故事